+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Support to the network of National Cancer Mission Hubs (NCMHs)

European Commission

Expected Outcome:

This topic will ensure the continuation of the work of supporting the creation of a Network of National Cancer Mission Hubs (NCMHs) in Member States and Associated Countries. NCMHs in each Member State and Associate Country are to operate for the whole duration of the Cancer Mission and beyond. It was envisaged that there would be a second phase of support to build on the achievements and needs identified under the ECHoS project[1] during the first phase.

Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes:

The Network and NCMHs are supported to ensure the integration of Cancer Mission activities at national, regional, and local levels;
Stakeholders, including patients and citizens, in national, regional or local health and research and innovation systems engage in policy dialogues on cancer;
Citizens, including patients, are involved in citizen engagement activities, including their design and development, which will lead to recommendations being made to governments, helping to implement and adapt strategies to national and regional needs;
Regional and national policy makers and authorities benefit from activities carried out in the implementation of Cancer Mission actions.

Scope:

Building on the first phase of NCMHs, the Mission's activities will be coordinated with relevant national, regional or local actors with a view to facilitate their integration and alignment with EU and national initiatives such as Europe's Beating Cancer Plan and national cancer strategies and/or national cancer control plans. The Network and NCMHs will be strengthened, including through expanding its capacities, outreach and type of activities the Network will carry out, while ensuring its sustainability.

In this regard the proposal should support the operation of the Network and activities carried out by it.

The proposal should address all of the following:

Enhance the capacity of NCMHs in the Member States and Associated Countries, through knowledge exchange and training, and expanding the geographical outreach of the NCMHs activities in each country;
Support the Networks' work such as coordination of joint activities of NCMHs and awareness raising of the Cancer Mission activities including coordination of EU cancer research activities and policy actions;
Develop a methodology on mission-driven implementation of Mission actions with a view to building synergies at national and regional levels;
Support the engagement of relevant national, regional or local actors, including civil society as well as business and legal advisors, including those who haven't been involved previously, in regular thematic policy dialogues and country-specific dialogues on cancer to increase the impact of EU cancer-related R&I and policies at national, regional and local level;
Organise regular citizen engagement activities, at least one per year related to the objectives of the Mission, such as on prevention or screening and/or organise activities for a country or a number of countries using tools and materials developed by the European Observatory on Health Systems and Policies[2] in each Member State and Associated Country, with a view to increase awareness and participation in policy discussions;
Develop strategies for NCMHs to reach long-term sustainability and to create a level of interest from stakeholders including from philanthropy, to attract private funding beyond EU programmes in support of NCMHs;
Disseminate the results of NCMHs Networks’ activities, through organisation of a yearly conference and development of policy reports;
Provide a yearly summary report of national Mission-related activities to contribute to the monitoring of progress of the Mission implementation at national and regional levels;
Organise regular exchanges of best practices between the NCMHs and hubs of the other four missions, e.g. in the area of stakeholder and citizen engagement, long-term sustainability of mission hubs, and building of synergies;
Work closely with Horizon Europe National Contact Points to enhance their activities, such as raising awareness about Cancer Mission funding activities through information events (e.g. info-days, conferences, mutual-learning events, brokerage events, and fairs) and communication tools. Collaborate closely with Cancer Mission Board members to engage new stakeholders, and to mobilise and align additional funding in support of NCMHs;
Work closely with relevant international institutions and initiatives addressing science-policy interaction relevant to the Cancer Mission, including relevant OECD initiatives aiming at strengthening evidence-informed policy making for mission-oriented innovation (e.g. contributing to the Community of Practice through mutual learning, workshops and networking initiatives);
Establish appropriate collaboration with the consortium implementing HORIZON-MISS-2024-CANCER-01-06 for joint activities[3] such as dissemination and outreach related to the national nodes of the European Cancer Patient Digital Centre (ECPDC)[4].

AI Based Application Success Predictor

🧪 1. Scientific Excellence Is Paramount

For ERC grants, excellence is the sole selection criterion—evaluations focus exclusively on the quality of the research and track record .

Peer-reviewers adhere strictly to predefined criteria (e.g., Horizon ITN evaluations), and weaknesses—rather than strengths—often decide the outcome .

🌍 2. Strategic Alignment with EU Priorities

Horizon Europe emphasizes Green & Digital Transitions and resilience, with specific budget steering across biodiversity, climate, digital, and societal missions .

Proposals that clearly align with these strategic orientations and EU missions are significantly more competitive.

🤝 3. Strong, Diverse European Consortia

Horizon projects demand well-balanced consortia across Europe—geographically and disciplinarily diverse, including academia, industry, SMEs, NGOs .

Effective leadership, communication, trust, and active collaboration are key success factors.

🧴 4. Proven Research Infrastructure & Track Record

A strong publication record—especially in high-impact venues—and prior grant awards bolster chances .

ERC starting, consolidator, or advanced grants require exceptional citation records, strong proposals, and investigator track records .

📈 5. Robust Project Management

For large collaborative grants, project coordination, administration, and communication are just as crucial as scientific content .

Demonstrating realistic budget planning (100% direct costs + 25% indirect costs), administrative frameworks, and governance structures strengthens proposals .

💼 6. Fostering Mobility & Career Growth

Marie Skłodowska-Curie fellowships emphasize researcher mobility, interdisciplinary training, and developing future talent .

🧷 7. Geographical & Gender Equity

Northern and certain Eastern European institutions currently have higher success rates (≈22% vs below 18% in Southern Europe) .

ERC gender data: male and female applicants have similar success rates, though male applicants apply more frequently .

📌 Key Takeaways

Factor	Why It Matters
Excellence-first	Superior science and investigator record are non-negotiable.
Strategic fit	Alignment with EU green, digital, and mission goals is essential.
Consortium quality	Geographic, sectoral, and expertise balance enhances impact.
Management capacity	Good PM builds confidence in successful delivery.
Experience track record	Publications, previous funding, and citations build credibility.
Mobility & careers	MSCA focuses on researcher development and interdisciplinary collaboration.

🧭 Applicant Tips

Master criteria & avoid weaknesses: Make sure your proposal addresses common reviewer pitfalls—methodology, innovation, budget clarity.

Map to EU priorities: Explicitly connect your objectives to Horizon Europe’s strategic plan (2025–2027).

Build strong consortia early: Prioritize complementary expertise, geography, gender balance, and partner roles.

Show robust project management: Include a Work Package structure, governance plans, and clear communication strategies.

Leverage your track record: Highlight high-impact papers, leadership in projects, and previous awards.

Consider MSCA opportunities: Use them for mobility grants or integrating training into your project.

✅ In Summary

To maximize success with European Commission grants—especially ERC or Horizon Europe—focus relentlessly on scientific excellence, strategic EU alignment, consortium strength, and solid project planning. Combine these with a strong publication record and researcher development elements, and aim to close off any potential reviewer concerns.

Specialties

Cancer

Eligibility Requirements

General conditions

1. Admissibility Conditions: Proposal page limit and layout

described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.

2. Eligible Countries

described in Annex B of the Work Programme General Annexes.

A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

3. Other Eligible Conditions

described in Annex B of the Work Programme General Annexes.

4. Financial and operational capacity and exclusion

described in Annex C of the Work Programme General Annexes.

5a. Evaluation and award: Award criteria, scoring and thresholds

are described in Annex D of the Work Programme General Annexes.

5b. Evaluation and award: Submission and evaluation processes

The thresholds for each criterion will be 4 (Excellence), 4 (Impact) and 4 (Implementation). The cumulative threshold is 12.

are described in Annex F of the Work Programme General Annexes and the Online Manual.

5c. Evaluation and award: Indicative timeline for evaluation and grant agreement

described in Annex F of the Work Programme General Annexes.

6. Legal and financial set-up of the grants

Eligible costs will take the form of a lump sum as defined in the Decision of 7 July 2021 authorising the use of lump sum contributions under the Horizon Europe Programme – the Framework Programme for Research and Innovation (2021-2027) – and in actions under the Research and Training Programme of the European Atomic Energy Community (2021-2025) [[This decision is available on the Funding and Tenders Portal, in the reference documents section for Horizon Europe, under ‘Simplified costs decisions’ or through this link: https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/ls-decision_he_en.pdf]].

described in Annex G of the Work Programme General Annexes.

Specific conditions

described in the [specific topic of the Work Programme]

Sponsor Details

Sponsor Institute/Organizations: European Commission

Sponsor Type: Corporate/Non-Profit

Address: Rue de la Loi 200, 1049 Brussels, Belgium

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity